Company Filing History:
Years Active: 2014-2022
Title: Collin Chan: Innovator in Pharmaceutical Chemistry
Introduction
Collin Chan is a notable inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug preparation. With a total of 3 patents to his name, Chan continues to push the boundaries of scientific research and innovation.
Latest Patents
Chan's latest patents include a process for the preparation of N-((1R,2S,5R)-5-(-butylamino)-2-((S)-3-(7--butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide. This invention generally relates to an improved method for synthesizing this complex compound. Another significant patent is for the preparation of cycloheptapyridine CGRP receptor antagonists, which includes synthetic intermediates that are useful in the overall process.
Career Highlights
Collin Chan is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work focuses on developing innovative solutions that address unmet medical needs. Chan's expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Chan has collaborated with esteemed colleagues, including David Kenneth Leahy and Yu Fan. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Collin Chan exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborative efforts continue to advance the field of drug development. Chan's work not only reflects his dedication to science but also his commitment to improving healthcare outcomes.